Kala Bio Inc (NAS:KALA)
$ 6.79 -0.075 (-1.09%) Market Cap: 19.12 Mil Enterprise Value: 4.76 Mil PE Ratio: 0 PB Ratio: 2.50 GF Score: 49/100

Kala Pharmaceuticals Inc Annual Shareholders Meeting Transcript

Jun 25, 2020 / 01:00PM GMT
Release Date Price: $585 (+3.91%)
Operator

Good morning, ladies and gentlemen, and welcome to the Kala Pharmaceuticals 2020 Annual Meeting of Stockholders.

I will now turn the program over to the CEO, President and Chairman of the Board of Kala, Mark Iwicki. Mark, you may begin.

Mark T. Iwicki
Kala Pharmaceuticals, Inc. - Chairman, President & CEO

Thank you very much, operator. Good morning, and welcome to the 2020 Annual Meeting of Stockholders of Kala Pharmaceuticals, Inc. I'm Mark Iwicki, Chief Executive Officer, President and Chairman of the Board of Kala Pharmaceuticals, Inc., and I will be presiding over this meeting.

I welcome you and call the meeting to order.

Due to the public health impact of the COVID-19 pandemic and to support the health and well-being of our stockholders, employees and communities, this year, we are holding our annual meeting in an all-virtual format and are pleased to have everyone join this live webcast.

We have designed this meeting to provide stockholders the same rights and opportunities to participate as they would at an in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot